Skip to main content
. 2010 Jan 25;115(25):5180–5190. doi: 10.1182/blood-2009-06-228288

Table 4.

Antigen expression

Patient ID None Labetuzumab (CEA, isotype control) IMMU-114 (HLA-DR) Milatuzumab (CD74) Epratuzumab (CD22) Veltuzumab (CD20)
CLL030 4.5 4.5 23.2 6.8 5.3 20.1
CLL037 4.6 5.6 505.8 15.5 10.1 87.2
CLL078 4.8 7.0 919.0 30.9 7.7 284.3
CLL107 15.6 10.9 148.6 11.9 12.5 85.0
CLL113 15.4 23.0 728.6 59.9 26.2 411.3
CLL117 21.6 23.4 90.9 30.2 25.2 111.0

Values are mean fluorescence intensities.